ASTROTECH Corp Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
ASTROTECH Corp (ASTC) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 924.00 thousand shares for the 12-month period ending 2017-06-30, per its 10-K filed 2017-09-18.
Discontinued › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2017-09-18
- ASTROTECH Corp share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2017 was 924.00K shares, a 443.53% increase from fiscal 2016.
- ASTROTECH Corp share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2016 was 170.00K shares, a 58.44% decline from fiscal 2015.
- ASTROTECH Corp share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2015 was 409.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month |
|---|---|
| 2017-06-30 | 924.00K shares 10-K · filed 2017-09-18 |
| 2016-06-30 | 170.00K shares 10-K · filed 2017-09-18 |
| 2015-06-30 | 409.00K shares 10-K · filed 2016-09-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |